Velcade 3.5 mg, 1 vial (Bortezomib 3.5 mg) by Janssen.
Indications: Multiple myeloma and mantle cell lymphoma.
Administration: Intravenous or subcutaneous injection, 1.3 mg/m² per protocol schedule.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Janssen / Takeda |
| Active ingredient | Bortezomib 3.5 mg — proteasome inhibitor. |
| Strength & pack | 1 single-use vial. |
| Form | Powder for solution for injection |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |